Perimenopause
Navigate the menopausal transition with confidence and clear information
Overview
Perimenopause is the transitional period leading up to menopause, when the ovaries gradually produce less estrogen. It typically begins in the mid-40s (range 39-51) and averages 4 to 8 years. Diagnosis is clinical -- FSH levels are unreliable due to hormonal fluctuations during this phase.
Symptoms span multiple body systems: vasomotor (hot flashes, night sweats), neurological (brain fog, mood changes, insomnia), genitourinary (vaginal dryness, urinary issues), musculoskeletal (joint pain), and metabolic (weight redistribution). These symptoms can be unpredictable and are often dismissed or misattributed to stress, depression, or aging.
Hormone therapy (HT) is the most effective treatment for vasomotor symptoms, and modern evidence strongly supports its safety when initiated within 10 years of menopause onset or before age 60. Transdermal estrogen with micronized progesterone is the preferred regimen for most people. Non-hormonal options, including newer medications like fezolinetant, provide effective alternatives for those who cannot or choose not to use hormones.
Symptoms
Hot flashes and night sweats
Sudden waves of heat, flushing, and sweating that can occur day or night, disrupting sleep and daily activities.
Brain fog and memory changes
Difficulty concentrating, word-finding problems, and forgetfulness that are neurological effects of fluctuating estrogen.
Mood changes
Increased anxiety, irritability, depression, or emotional lability that may be new or represent worsening of existing tendencies.
Sleep disruption
Difficulty falling or staying asleep, often related to night sweats but also caused by changing hormone levels directly.
Vaginal dryness and discomfort
Thinning and drying of vaginal tissue that can cause discomfort, pain during sex, and increased UTI risk.
Irregular periods
Cycles that become longer, shorter, heavier, lighter, or unpredictable as ovulation becomes inconsistent.
Joint and muscle pain
New or worsening joint stiffness and muscle aches related to declining estrogen levels.
Weight redistribution
Shift in body composition and fat distribution, particularly to the midsection, due to metabolic changes.
Treatment Options
Hormone therapy (HT)
Transdermal estrogen (patch/gel) with micronized progesterone is the most effective treatment for vasomotor symptoms. Lower VTE risk than oral estrogen.
Vaginal estrogen
Local estrogen (cream, ring, or tablet) is safe for nearly all women and effectively treats genitourinary symptoms without systemic HT risks.
Non-hormonal medications
SSRIs/SNRIs, gabapentin, and fezolinetant (NK3 antagonist) provide effective relief for those who cannot use hormones.
Exercise and nutrition
Regular aerobic and resistance exercise supports bone density, mood, sleep, and metabolic health. Mediterranean diet and adequate calcium/vitamin D are recommended.
CBT and mind-body approaches
Cognitive behavioral therapy is effective for mood, sleep, and hot flash management. Hypnotherapy has evidence for vasomotor symptom reduction.
Bone health monitoring
DEXA screening at menopause for high-risk women. Weight-bearing and resistance exercise is essential for maintaining bone density.
Frequently Asked Questions
Have Questions About Perimenopause?
Romy can answer your questions, help you track symptoms, and prepare you for doctor visits with personalized, evidence-based guidance.
Related Conditions
Thyroid & Reproductive Health
Understand how thyroid disorders uniquely impact women's health and fertility
PMDD (Premenstrual Dysphoric Disorder)
Recognize and manage PMDD -- a real neurobiological condition, not "just PMS"
PCOS (Polycystic Ovary Syndrome)
Navigate PCOS with evidence-based information on diagnosis and management
Important Notice
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider for medical decisions specific to your situation.